Literature DB >> 17258130

Management of skull based meningiomas in the elderly patient.

F Roser1, F H Ebner, R Ritz, M Samii, M S Tatagiba, M Nakamura.   

Abstract

BACKGROUND: The demographic evolution of Western society together with availability of modern imaging techniques leads to an increasing diagnosis of meningioma patients over 70 years of age. This raises the question of appropriate management of this histologically benign tumour in a geriatric population.
DESIGN: Forty-three patients aged over 70 years were analyzed and matched in a retrospective study with a younger group of 89 patients according to tumour size, histology, symptoms, recurrence and presence of neurofibromatosis II.
RESULTS: Changes in postoperative Karnofsky scores were not statistically different between the two age groups. Neurological outcome was worse among the younger group (12% vs. 7% deterioration). Regarding surgical complications we noted only a statistically significant higher infection rate in the geriatric age group. There was no peri-operative mortality.
CONCLUSIONS: Age alone is not a criterion to deny a priori skull base surgery, since well selected geriatric patients may benefit from a meningioma operation that may enhance future quality of life.

Entities:  

Mesh:

Year:  2007        PMID: 17258130     DOI: 10.1016/j.jocn.2005.12.004

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  14 in total

1.  Management of incidental anterior skull base large and giant meningiomas in elderly patients.

Authors:  Yuqian Li; Dan Lu; Dayun Feng; Hongyu Cheng; Qian Huang; Haikang Zhao; Peng Chen; Huaizhou Qin; Qing Cai
Journal:  J Neurooncol       Date:  2020-06-11       Impact factor: 4.130

2.  Instruments for estimation of health-related quality of life in patients with skull base neoplasms.

Authors:  Mariana E Witgert; Tracy Veramonti; Ehab Hanna
Journal:  Skull Base       Date:  2010-01

3.  Quality-of-Life after Anterior Skull Base Surgery: A Systematic Review.

Authors:  Matthew A Kirkman; Anouk Borg; Alaa Al-Mousa; Nikolaos Haliasos; David Choi
Journal:  J Neurol Surg B Skull Base       Date:  2013-12-11

4.  Case Series of Skull Base Meningioma Resection in the Octogenarian Population.

Authors:  Dorian M Kusyk; Gordon Mao; Rocco Dabecco; Alexander K Yu
Journal:  J Neurol Surg B Skull Base       Date:  2021-02-18

5.  Perioperative Complication Profile of Skull Base Meningioma Resection in Older versus Younger Adult Patients.

Authors:  Colin J Przybylowski; Kelly A Shaftel; Benjamin K Hendricks; Kristina M Chapple; Shawn M Stevens; Randall W Porter; Nader Sanai; Andrew S Little; Kaith K Almefty
Journal:  J Neurol Surg B Skull Base       Date:  2021-10-12

Review 6.  FACT-MNG: tumor site specific web-based outcome instrument for meningioma patients.

Authors:  D Zlotnick; S N Kalkanis; A Quinones-Hinojosa; K Chung; M E Linskey; R L Jensen; F DeMonte; F G Barker; C A Racine; M S Berger; P M Black; M Cusimano; L N Sekhar; A Parsa; M Aghi; Michael W McDermott
Journal:  J Neurooncol       Date:  2010-09-18       Impact factor: 4.130

7.  [Modern surgery of meningiomas affecting anterior visual pathways].

Authors:  F Grimm; F H Ebner; J Honegger
Journal:  Ophthalmologe       Date:  2013-05       Impact factor: 1.059

8.  Outcome comparison between younger and older patients undergoing intracranial meningioma resections.

Authors:  Michael Tin-Chung Poon; Linus Hing-Kai Fung; Jenny Kan-Suen Pu; Gilberto Ka-Kit Leung
Journal:  J Neurooncol       Date:  2013-06-05       Impact factor: 4.130

9.  Meningioma surgery in younger and older adults: patient profile and surgical outcomes.

Authors:  K Mariam Slot; Jocelyne V M Peters; W Peter Vandertop; Dagmar Verbaan; Saskia M Peerdeman
Journal:  Eur Geriatr Med       Date:  2017-12-21       Impact factor: 1.710

10.  Reduction of thromboembolic events in meningioma surgery: a cohort study of 724 consecutive patients.

Authors:  Christian Valentin Eisenring; Marian Christoph Neidert; Daniel Sabanés Bové; Leonhard Held; Johannes Sarnthein; Niklaus Krayenbühl
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.